drugset / Trial / NCT04097951
HDDO-1801 Intervention Trial
RandomizedCrossoverOpen-labelOther
Summary
A randomized, open-label, single-dose, 3-period, 6-sequence, 3-way crossover study
Timeline
- Start
- 2019-11-08
- Primary completion
- 2020-01-08
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bepotastine | Small molecule | — | Oral |
| Subject | Montelukast | Other / unclassified | — | Oral |